These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12899534)

  • 1. Prospects for vitamin D receptor modulators as candidate drugs for cancer and (auto)immune diseases.
    Bouillon R; Verstuyf A; Verlinden L; Eelen G; Mathieu C
    Recent Results Cancer Res; 2003; 164():353-6. PubMed ID: 12899534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms for the selective action of Vitamin D analogs.
    Bouillon R; Verlinden L; Eelen G; De Clercq P; Vandewalle M; Mathieu C; Verstuyf A
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):21-30. PubMed ID: 16111885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in the use of vitamin D analogues.
    Verstuyf A; Segaert S; Verlinden L; Bouillon R; Mathieu C
    Expert Opin Investig Drugs; 2000 Mar; 9(3):443-55. PubMed ID: 11060686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The development of vitamin D analogs as a therapeutic agent].
    Nakagawa K; Okano T
    Seikagaku; 2003 Sep; 75(9):1233-8. PubMed ID: 14577354
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D analogs: therapeutic applications and mechanisms for selectivity.
    Brown AJ; Slatopolsky E
    Mol Aspects Med; 2008 Dec; 29(6):433-52. PubMed ID: 18554710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative role of vitamin D and its analogs--a brief overview.
    Banerjee P; Chatterjee M
    Mol Cell Biochem; 2003 Nov; 253(1-2):247-54. PubMed ID: 14619976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
    Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
    J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
    Choi M; Makishima M
    Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative Activity of Non-Calcemic Vitamin D Analogs on Human Melanoma Lines in Relation to VDR and PDIA3 Receptors.
    Wasiewicz T; Piotrowska A; Wierzbicka J; Slominski AT; Zmijewski MA
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D, disease and therapeutic opportunities.
    Plum LA; DeLuca HF
    Nat Rev Drug Discov; 2010 Dec; 9(12):941-55. PubMed ID: 21119732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells.
    Mathiasen IS; Colston KW; Binderup L
    J Steroid Biochem Mol Biol; 1993 Sep; 46(3):365-71. PubMed ID: 9831485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2beta-(3-hydroxypropoxy)calcitriol (ED-71).
    Nishii Y; Okano T
    Steroids; 2001; 66(3-5):137-46. PubMed ID: 11179721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in research on vitamin D analogs].
    Kubodera N
    Clin Calcium; 2006 Jul; 16(7):1167-72. PubMed ID: 16816477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
    Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
    Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological effects of vitamin D and its analogs: recent developments.
    Sintov AC; Yarmolinsky L; Dahan A; Ben-Shabat S
    Drug Discov Today; 2014 Nov; 19(11):1769-1774. PubMed ID: 24947685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma and vitamin D: a review.
    Chiang KC; Yeh CN; Chen MF; Chen TC
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1597-603. PubMed ID: 21880026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncalcemic actions of vitamin D receptor ligands.
    Nagpal S; Na S; Rathnachalam R
    Endocr Rev; 2005 Aug; 26(5):662-87. PubMed ID: 15798098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune modulation by vitamin D analogs in the prevention of autoimmune diseases].
    Bouillon R; Verstuyf A; Branisteanu D; Waer M; Mathieu C
    Verh K Acad Geneeskd Belg; 1995; 57(5):371-85; discussion 385-7. PubMed ID: 8571669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of human breast carcinoma cells by a novel vitamin D analog: 1alpha-hydroxyvitamin D5.
    Mehta RR; Bratescu L; Graves JM; Green A; Mehta RG
    Int J Oncol; 2000 Jan; 16(1):65-73. PubMed ID: 10601550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.